Tag: Cerebral cavernous malformation

While historical advice has cautioned against the use of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen in patients with cerebral cavernous malformations (CCM), also known as cavernomas, emerging evidence indicates that the risk of hemorrhage from intermittent use may not be as high as once thought. The question, 'Can you take ibuprofen with a cavernoma?' is nuanced and should always be discussed with a specialist well-versed in CCM.

Affecting approximately 1 in every 500 people, cerebral cavernous malformations (CCM), or cavernomas, are abnormal clusters of thin-walled blood vessels in the brain and spinal cord. While no FDA-approved medication exists to directly cure cavernoma lesions, ongoing research is exploring targeted therapies to manage bleeding and stabilize these lesions.